Functional Control of Viremiain CCR5-Δ32 Heterozygous (Δ32HZ) HIV+ Subjects Following Adoptive Transfer of Zinc Finger Nuclease CCR5 Modified AutologousCD4 T-cells (SB-728-T)
Reported by Jules Levin
53rd ICAAC -Denver, Colorado
September 12, 2013
Dale Ando, MD
VP Therapeutic Development & CMO
SangamoBioSciences, Inc.
